Literature DB >> 15936964

Analysis of actinomycin D-DNA model complexes using a quantum-chemical criterion: Mulliken overlap populations.

Cezar Bendic1, Mirela Enache, Elena Volanschi.   

Abstract

The binding of the antitumoral drug actinomycin D to single- and double-stranded DNA was investigated using molecular modeling in the frame of MM+ molecular mechanics and AM1 semi-empirical method. Two other programs, especially conceived to analyze hydrogen-bonding patterns in biological macromolecules, HBexplore, based on geometrical criteria and SHB_interactions, based on quantum-chemical criteria (Mulliken overlap populations), were also used. The results account for the non-cooperative intercalative binding process previously investigated, and outline the contribution of specific hydrogen bonding as well as CH...O(N) and other atom-atom intermolecular interactions to the stabilization of the actinomycin D-DNA complexes. They also support the hemi-intercalation model proposed in literature for the actinomycin D-ssDNA complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936964     DOI: 10.1016/j.jmgm.2005.03.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  3 in total

1.  Theoretical investigation into the cooperativity effect between the intermolecular π∙π and H-bonding interactions in the curcumin∙cytosine∙H2O system.

Authors:  Jie Pan; Duan-Lin Cao; Fu-de Ren; Jian-Long Wang; Lu Yang
Journal:  J Mol Model       Date:  2018-09-28       Impact factor: 1.810

2.  The nature of the chemical bond in oxyanionic crystals based on QTAIM topological analysis of electron densities.

Authors:  Dmitry V Korabel'nikov; Yuriy N Zhuravlev
Journal:  RSC Adv       Date:  2019-04-16       Impact factor: 4.036

Review 3.  What Can Electrochemical Methods Offer in Determining DNA-Drug Interactions?

Authors:  Sandra Ramotowska; Aleksandra Ciesielska; Mariusz Makowski
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.